Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100B

International Immunology

Volumn 23, Issue 12, 2011, Pages 713-728

  Curran, Colleen S ^a   Bertics, Paul J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

CD11b; GM CSF; IL 5; S100A8; S100A9

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CALCYCLIN; CALGRANULIN A; CALGRANULIN B; CALVASCULIN; COMPLEMENTARY DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 5; MESSENGER RNA; PROTEIN KINASE C DELTA; PROTEIN S100 A11; PROTEIN S100 P; PROTEIN S100B; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; EOSINOPHIL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; SEQUENCE ANALYSIS; UPREGULATION;

ANTIGENS, NEOPLASM; CELL LINE; CELL SURVIVAL; COMPUTATIONAL BIOLOGY; ENZYME ACTIVATION; EOSINOPHILS; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-5; LIGANDS; MICROARRAY ANALYSIS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE C-DELTA; S100 PROTEINS;

EID: 82855161550     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxr083     Document Type: Article

References (101)

1. Hogan, S. P. 2007. Recent advances in eosinophil biology. Int. Arch. Allergy Immunol. 143 (Suppl. 1):3.
2. Schmidt, A. M., Yan, S. D., Yan, S. F. and Stern, D. M. 2001. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 108:949.
3. Jing, R. R., Cui, M., Sun, B. L., Yu, J. and Wang, H. M. 2010. Tissue-specific expression profiling of receptor for advanced glycation end products and its soluble forms in esophageal and lung cancer. Genet. Test. Mol. Biomarkers 14:355.
4. Salama, I., Malone, P. S., Mihaimeed, F. and Jones, J. L. 2008. A review of the S100 proteins in cancer. Eur. J. Surg. Oncol. 34:357.
5. Gebhardt, C., Riehl, A., Durchdewald, M. et al. 2008. RAGE signaling sustains inflammation and promotes tumor development. J. Exp. Med. 205:275.
6. Cormier, S. A., Taranova, A. G., Bedient, C. et al. 2006. Pivotal Advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J. Leukoc. Biol. 79:1131.
7. Sen, J. and Belli, A. 2007. S100B in neuropathologic states: the CRP of the brain? J. Neurosci. Res. 85:1373.
8. Steiner, J., Marquardt, N., Pauls, I. et al. 2011. Human CD8(+) T cells and NK cells express and secrete S100B upon stimulation. Brain Behav. Immun. 7:1233.
9. Raap, U. and Wardlaw, A. J. 2008. A new paradigm of eosinophil granulocytes: neuroimmune interactions. Exp. Dermatol. 17:731.
10. Powell, N., Walker, M. M. and Talley, N. J. 2010. Gastrointestinal eosinophils in health, disease and functional disorders. Nat. Rev. Gastroenterol. Hepatol. 7:146.
11. Denburg, J. A. and Keith, P. K. 2008. Eosinophil progenitors in airway diseases: clinical implications. Chest 134:1037.
12. Hogan, S. P., Rosenberg, H. F., Moqbel, R. et al. 2008. Eosinophils: biological properties and role in health and disease. Clin. Exp. Allergy 38:709.
13. Walker, M. M., Warwick, A., Ung, C. and Talley, N. J. 2011. The role of eosinophils and mast cells in intestinal functional disease. Curr. Gastroenterol. Rep. 4:323.
14. Halayko, A. J. and Ghavami, S. 2009. S100A8/A9: a mediator of severe asthma pathogenesis and morbidity? Can. J. Physiol. Pharmacol. 87:743.
15. Leach, S. T., Yang, Z., Messina, I. et al. 2007. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand. J. Gastroenterol. 42:1321.
16. Herold, K., Moser, B., Chen, Y. et al. 2007. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress. J. Leukoc. Biol. 82:204.
17. Hudson, B. I., Carter, A. M., Harja, E. et al. 2008. Identification, classification, and expression of RAGE gene splice variants. FASEB J. 22:1572.
18. Raucci, A., Cugusi, S., Antonelli, A. et al. 2008. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J. 22:3716.
19. Buckley, S. T., Medina, C., Kasper, M. and Ehrhardt, C. 2011. Interplay between RAGE, CD44, and focal adhesion molecules in epithelial-mesenchymal transition of alveolar epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 300:L548.
20. Wang, Y., Wang, H., Piper, M. G. et al. 2010. sRAGE induces human monocyte survival and differentiation. J. Immunol. 185:1822.
21. Friggeri, A., Banerjee, S., Biswas, S. et al. 2011. Participation of the receptor for advanced glycation end products in efferocytosis. J. Immunol. 186:6191.
22. He, M., Kubo, H., Morimoto, K. et al. 2011. Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells. EMBO Rep. 12:358.
23. Kyoh, S., Kanazawa, H., Tochino, Y., Kodama, T., Asai, K. and Hirata, K. 2008. Comparison of N-epsilon-(Carboxymethyl)Lysine levels and percentage of eosinophils in induced sputum for assessment of small airway involvements in asthma. Med. Sci. Monit. 14:CR375.
24. Bates, M. E., Liu, L. Y., Esnault, S. et al. 2004. Expression of interleukin-5- and granulocyte macrophage-colony-stimulating factor-responsive genes in blood and airway eosinophils. Am. J. Respir. Cell. Mol. Biol. 30:736.
25. Trivedi, S. G. and Lloyd, C. M. 2007. Eosinophils in the pathogenesis of allergic airways disease. Cell. Mol. Life Sci. 64:1269.
26. Donato, R. 2007. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr. Mol. Med. 7:711.
27. Tian, L., Rauvala, H. and Gahmberg, C. G. 2009. Neuronal regulation of immune responses in the central nervous system. Trends Immunol. 30:91.
28. Lotze, M. T., Zeh, H. J., Rubartelli, A. et al. 2007. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol. Rev. 220:60.
29. Korpi-Steiner, N. L., Bates, M. E., Lee, W. M., Hall, D. J. and Bertics, P. J. 2006. Human rhinovirus induces robust IP-10 release by monocytic cells, which is independent of viral replication but linked to type I interferon receptor ligation and STAT1 activation. J. Leukoc. Biol. 80:1364.
30. Ostendorp, T., Leclerc, E., Galichet, A. et al. 2007. Structural and functional insights into RAGE activation by multimeric S100B. EMBO J. 26:3868.
31. Hall, T. A. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl. Acids Symp. Ser. 41:95.
32. Lotfi, R., Herzog, G. I., DeMarco, R. A. et al. 2009. Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells. J. Immunol. 183:5023.
33. Ishiguro, H., Nakaigawa, N., Miyoshi, Y., Fujinami, K., Kubota, Y. and Uemura, H. 2005. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development. Prostate 64:92.
34. Bartling, B., Hofmann, H. S., Weigle, B., Silber, R. E. and Simm, A. 2005. Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma. Carcinogenesis 26:293.
35. Kuniyasu, H., Chihara, Y., Kondo, H., Ohmori, H. and Ukai, R. 2003. Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer. Oncol. Rep. 10:1863.
36. Bierhaus, A., Stern, D. M. and Nawroth, P. P. 2006. RAGE in inflammation: a new therapeutic target? Curr. Opin. Investig. Drugs 7:985.
37. Zhang, L., Bukulin, M., Kojro, E. et al. 2008. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases. J. Biol. Chem. 283:35507.
38. Yui, S., Nakatani, Y. and Mikami, M. 2003. Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol. Pharm. Bull. 26:753.
39. Foell, D., Wittkowski, H., Ren, Z. et al. 2008. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J. Pathol. 216:183.
40. Nitti, M., Furfaro, A. L., Traverso, N. et al. 2007. PKC delta and NADPH oxidase in AGE-induced neuronal death. Neurosci. Lett. 416:261.
41. Matron, C., Chakravarti, A., Allaeys, I. and Poubelle, P. E. 2010. PKC-delta controls the fMLF-induced overproduction of superoxide by neutrophils. Free Radic. Biol. Med. 48:207.
42. Donato, R. 2001. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33:637.
43. Yamaguchi, T., Suzuki, M., Kimura, H. and Kato, M. 2006. Role of protein kinase C in eosinophil function. Allergol. Int. 55:245.
44. Giembycz, M. A. and Lindsay, M. A. 1999. Pharmacology of the eosinophil. Pharmacol. Rev. 51:213.
45. Sevillano, N., Giron, M. D., Salido, M., Vargas, A. M., Vilches, J. and Salto, R. 2009. Internalization of the receptor for advanced glycation end products (RAGE) is required to mediate intracellular responses. J. Biochem. 145:21.
46. Hermani, A., De Servi, B., Medunjanin, S., Tessier, P. A. and Mayer, D. 2006. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp. Cell Res. 312:184.
47. Sugaya, K., Fukagawa, T., Matsumoto, K. et al. 1994. Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics 23:408.
48. Vissing, H., Aagaard, L., Tommerup, N. and Boel, E. 1994. Localization of the human gene for advanced glycosylation end product-specific receptor (AGER) to chromosome 6p.21.3. Genomics 24:606.
49. Shiina, T., Inoko, H. and Kulski, J. K. 2004. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 64:631.
50. Ghavami, S., Rashedi, I., Dattilo, B. M. et al. 2008. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J. Leukoc. Biol. 83:1484.
51. Lagasse, E. and Clerc, R. G. 1988. Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation. Mol. Cell. Biol. 8:2402.
52. Yamaguchi, T., Kimura, H., Kurabayashi, M., Kozawa, K. and Kato, M. 2008. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colonystimulating factor or interleukin-5. Immunol. Lett. 118:88.
53. Qin, Y. H., Dai, S. M., Tang, G. S. et al. 2009. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p.38 through receptor for advanced glycation end products. J. Immunol. 183:6244.
54. Sano, M., Leff, A. R., Myou, S. et al. 2005. Regulation of interleukin-5-induced beta2-integrin adhesion of human eosinophils by phosphoinositide 3-kinase. Am. J. Respir. Cell. Mol. Biol. 33:65.
55. Hiraguri, M., Miike, S., Sano, H., Kurasawa, K., Saito, Y. and Iwamoto, I. 1997. Granulocyte-macrophage colony-stimulating factor and IL-5 activate mitogen-activated protein kinase through Jak2 kinase and phosphatidylinositol 3-kinase in human eosinophils. J. Allergy Clin. Immunol. 100:S45.
56. Guh, J. Y., Huang, J. S., Chen, H. C., Hung, W. C., Lai, Y. H. and Chuang, L. Y. 2001. Advanced glycation end product-induced proliferation in NRK-49F cells is dependent on the JAK2/STAT5 pathway and cyclin D1. Am. J. Kidney Dis. 38:1096.
57. Stout, B. A., Bates, M. E., Liu, L. Y., Farrington, N. N. and Bertics, P. J. 2004. IL-5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in human eosinophils. J. Immunol. 173:6409.
58. Vogl, T., Ludwig, S., Goebeler, M. et al. 2004. MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood 104:4260.
59. Bates, M. E., Sedgwick, J. B., Zhu, Y. et al. 2010. Human airway eosinophils respond to chemoattractants with greater eosinophilderived neurotoxin release, adherence to fibronectin, and activation of the Ras-ERK pathway when compared with blood eosinophils. J. Immunol. 184:7125.
60. Hobbs, J. A., May, R., Tanousis, K. et al. 2003. Myeloid cell function in MRP-14 (S100A9) null mice. Mol. Cell. Biol. 23:2564.
61. Bouma, G., Lam-Tse, W. K., Wierenga-Wolf, A. F., Drexhage, H. A. and Versnel, M. A. 2004. Increased serum levels of MRP-8/14 in type 1 diabetes induce an increased expression of CD11b and an enhanced adhesion of circulating monocytes to fibronectin. Diabetes 53:1979.
62. Burkhardt, K., Schwarz, S., Pan, C. et al. 2009. Myeloid-related protein 8/14 complex describes microcirculatory alterations in patients with type 2 diabetes and nephropathy. Cardiovasc. Diabetol. 8:10.
63. Barthe, C., Figarella, C., Carrere, J. and Guy-Crotte, O. 1991. Identification of 'cystic fibrosis protein' as a complex of two calcium-binding proteins present in human cells of myeloid origin. Biochim. Biophys. Acta 1096:175.
64. Terasaki, F., Fujita, M., Shimomura, H. et al. 2007. Enhanced expression of myeloid-related protein complex (MRP8/14) in macrophages and multinucleated giant cells in granulomas of patients with active cardiac sarcoidosis. Circ. J. 71:1545.
65. Altwegg, L. A., Neidhart, M., Hersberger, M. et al. 2007. Myeloidrelated protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. Eur. Heart J. 28:941.
66. Hirono, K., Foell, D., Xing, Y. et al. 2006. Expression of myeloidrelated protein-8 and -14 in patients with acute Kawasaki disease. J. Am. Coll. Cardiol. 48:1257.
67. Carroccio, A., Rocco, P., Rabitti, P. G. et al. 2006. Plasma calprotectin levels in patients suffering from acute pancreatitis. Dig. Dis. Sci. 51:1749.
68. Benoit, S., Toksoy, A., Ahlmann, M. et al. 2006. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis. Br. J. Dermatol. 155:62.
69. Frosch, M., Ahlmann, M., Vogl, T. et al. 2009. The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 60:883.
70. Chen, Y. S., Yan, W., Geczy, C. L., Brown, M. A. and Thomas, R. 2009. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis. Arthritis Res. Ther. 11:R39.
71. Jung, D. Y., Park, J. B., Lee, E. N. et al. 2008. Combined use of myeloid-related protein 8/14 and procalcitonin as diagnostic markers for acute allograft rejection in kidney transplantation recipients. Transpl. Immunol. 18:338.
72. Ikemoto, M., Matsumoto, S., Egawa, H. et al. 2007. A case with transient increases in serum S100A8/A9 levels implying acute inflammatory responses after pancreatic islet transplantation. Ann. Clin. Biochem. 44:570.
73. Bordmann, G., Burmeister, G., Saladin, S. et al. 1997. MRP 8/14 as marker for Plasmodium falciparum-induced malaria episodes in individuals in a holoendemic area. Clin. Diagn. Lab. Immunol. 4:435.
74. Kim, H. J., Kang, H. J., Lee, H. et al. 2009. Identification of S100A8 and S100A9 as serological markers for colorectal cancer. J. Proteome. Res. 8:1368.
75. Odegaard, E., Davidson, B., Elgaaen, B. V. et al. 2008. Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary. Am. J. Obstet. Gynecol. 198:418.e1.
76. Koller, D. Y., Urbanek, R. and Gotz, M. 1995. Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis. Am. J. Respir. Crit. Care Med. 152:629.
77. Saitoh, O., Kojima, K., Sugi, K. et al. 1999. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease. Am. J. Gastroenterol. 94:3513.
78. Miwa, N., Uebi, T. and Kawamura, S. 2008. S100-annexin complexes-biology of conditional association. FEBS J. 275:4945.
79. Sakaguchi, M., Sonegawa, H., Murata, H. et al. 2008. S100A11, an dual mediator for growth regulation of human keratinocytes. Mol. Biol. Cell. 19:78.
80. Cecil, D. L. and Terkeltaub, R. 2008. Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes. J. Immunol. 180:8378.
81. Schratl, P. and Heinemann, A. 2009. Differential involvement of Ca2+ and actin filament in leukocyte shape change. Pharmacology 83:131.
82. Kaatz, M., Berod, L., Czech, W. et al. 2004. Interleukin-5, interleukin-3 and granulocyte-macrophage colony-stimulating factor prime actin-polymerization in human eosinophils: a study with hypodense and normodense eosinophils from patients with atopic dermatitis. Int. J. Mol. Med. 14:1055.
83. Lowe, D., Jorizzo, J. and Hutt, M. S. 1981. Tumour-associated eosinophilia: a review. J. Clin. Pathol. 34:1343.
84. Langlois, A., Chouinard, F., Flamand, N., Ferland, C., Rola-Pleszczynski, M. and Laviolette, M. 2009. Crucial implication of protein kinase C (PKC)-delta, PKC-zeta, ERK-1/2, and p.38 MAPK in migration of human asthmatic eosinophils. J. Leukoc. Biol. 85:656.
85. Bankers-Fulbright, J. L., Kita, H., Gleich, G. J. and O'Grady, S. M. 2001. Regulation of human eosinophil NADPH oxidase activity: a central role for PKCdelta. J. Cell. Physiol. 189:306.
86. Dri, P., Cramer, R., Spessotto, P., Romano, M. and Patriarca, P. 1991. Eosinophil activation on biologic surfaces. Production of O2- in response to physiologic soluble stimuli is differentially modulated by extracellular matrix components and endothelial cells. J. Immunol. 147:613.
87. Donato, R., Sorci, G., Riuzzi, F. et al. 2009. S100B's double life: intracellular regulator and extracellular signal. Biochim. Biophys. Acta 1793:1008.
88. Rimmer, S. J., Akerman, C. L., Hunt, T. C., Church, M. K., Holgate, S. T. and Shute, J. K. 1992. Density profile of bronchoalveolar lavage eosinophils in the guinea pig model of allergen-induced late-phase allergic responses. Am. J. Respir. Cell. Mol. Biol. 6:340.
89. Bergmann, M. W., Staples, K. J., Smith, S. J., Barnes, P. J. and Newton, R. 2004. Glucocorticoid inhibition of granulocyte macrophage-colony-stimulating factor from T cells is independent of control by nuclear factor-kappaB and conserved lymphokine element 0. Am. J. Respir. Cell. Mol. Biol. 30:555.
90. Trutmann, M., Terracciano, L., Noppen, C. et al. 1998. GM-CSF gene expression and protein production in human colorectal cancer cell lines and clinical tumor specimens. Int. J. Cancer 77:378.
91. Hwang, C. C., Chai, H. T., Chen, H. W. et al. 2011. S100B protein expressions as an independent predictor of early relapse in UICC stages II and III colon cancer patients after curative resection. Ann. Surg. Oncol. 18:139.
92. Bennicelli, J. L. and Guerry, D. 1993. Production of multiple cytokines by cultured human melanomas. Exp. Dermatol. 2:186.
93. Harpio, R. and Einarsson, R. 2004. S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma. Clin. Biochem. 37:512.
94. Doherty, D. E. 2004. The pathophysiology of airway dysfunction. Am. J. Med. 117 (Suppl. 12A):11S.
95. Samoszuk, M. 1997. Eosinophils and human cancer. Histol. Histopathol. 12:807.
96. Hsieh, H. L., Schafer, B. W., Sasaki, N. and Heizmann, C. W. 2003. Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays. Biochem. Biophys. Res. Commun. 307:375.
97. Steiner, J., Bernstein, H. G., Bogerts, B. et al. 2008. S100B is expressed in, and released from, OLN-93 oligodendrocytes: influence of serum and glucose deprivation. Neuroscience 154:496.
98. Sheng, J. G., Mrak, R. E., Rovnaghi, C. R., Kozlowska, E., Van Eldik, L. J., and Griffin, W. S. 1996. Human brain S100 beta and S100 beta mRNA expression increases with age: pathogenic implications for Alzheimer's disease. Neurobiol. Aging 17:359.
99. Chaurand, P., Sanders, M. E., Jensen, R. A. and Caprioli, R. M. 2004. Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections. Am. J. Pathol. 165:1057.
100. Yamashima, T., Kubota, T. and Yamamoto, S. 1985. Eosinophil degranulation in the capsule of chronic subdural hematomas. J. Neurosurg. 62:257.
101. Nemeth, J., Stein, I., Haag, D. et al. 2009. S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology 50:1251.